C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2004
12/29/2004	EP0626008B1 Vaccine containing acemannan as an adjuvant
12/29/2004	EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CA2529053A1 Method for purifying virus
12/29/2004	CA2528002A1 Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
12/29/2004	CA2525953A1 High titer recombinant influenza viruses for vaccines and gene therapy
12/28/2004	US6835568 Regulated nucleic acid expression system
12/23/2004	WO2004111249A2 Protein constructs containing caspase recognition sites
12/23/2004	WO2004110484A1 Method for producing a live tissue-cultural vaccine against influenza virus
12/23/2004	WO2004110370A2 Etiologic agnet for sow infertility syndrome
12/23/2004	WO2003063679A8 Hepatitis e virus clones and methods of their use
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259255 Helper virus-free AAV production
12/23/2004	US20040259225 Virulent systemic feline calicivirus
12/23/2004	US20040259224 prevent or to treat Dengue infection; inducing an immune response to the four serotypes of dengue virus using a vaccine comprising four chimera comprising the capsid and non-structural proteins of Yellow Fever virus and the pre-membrane and envelope proteins of Dengue-1,-2,-3, and -4 virus types
12/23/2004	US20040258715 Porcine circoviruses, vaccines and diagnostic reagents
12/23/2004	US20040258714 Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
12/23/2004	US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy
12/22/2004	EP1489165A1 Recombinant fowlpox vaccine for protection against marek's disease
12/22/2004	EP1489164A1 Recombinant vaccinia viruses with modified F3 genes, uses thereof
12/22/2004	EP1488010A2 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
12/22/2004	EP1487983A2 Prevention of recurrence and metastasis of cancer
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	CN1556205A Method of purifying active virus
12/21/2004	US6833133 Escape mutants of Newcastle disease virus as marker vaccines
12/21/2004	US6833108 Method and apparatus for inactivating contaminants in blood products
12/16/2004	WO2004108940A2 Viral genome vectors
12/16/2004	WO2004108939A2 Bav packaging regions and e1 transcriptional control regions
12/16/2004	WO2004108936A1 Flavivirus replicon packaging system
12/16/2004	WO2004075861A3 Recombinant adeno-associated virus production
12/16/2004	WO2004000872A9 Improved alphavirus vectors having attenuated virion structural proteins
12/16/2004	WO2003092582B1 Chimeric ebola virus envelopes and uses therefor
12/16/2004	WO2003080823A8 Bacteriophages useful for therapy and prophylaxis of bacterial infections
12/16/2004	US20040255347 Using site specific recombination to insert heterologous nucleotide sequences into plants tissue; enhancing nutrient quality of plants; bioreactors
12/16/2004	US20040254147 Using hexafluorophosphate salt of pyridinium, imidazolium compound
12/16/2004	US20040253711 Mycobacterial genes down-regulated during latency
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253272 Process for producing inactivated virus envelopes
12/16/2004	US20040253271 Live attenuated viral vaccines for Eastern equine encephalitis virus
12/16/2004	US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome
12/16/2004	US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy
12/16/2004	US20040253210 replication-defective adenovirus type 7 that expresses one or more HIV polypeptides for use in stimulating an immune response to HIV-1; adenovirus serotype 7 cosmid vector; gene therapy
12/16/2004	CA2528252A1 Methods and kits for mass production of dsrna
12/16/2004	CA2528046A1 Flavivirus replicon packaging system
12/15/2004	EP1486211A1 Compositions for treating cancer using viruses
12/15/2004	EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines
12/15/2004	EP1485469A2 Virus like particle from papillomavirus and their use in vaccine
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1073461B1 Viral chimeras comprised of caev and hiv-1 genetic elements
12/15/2004	CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1554766A Pig breeding and respiratory syndrome recombined adenovirus and vaccine
12/15/2004	CN1554764A Recombinant mva virus, and the use thereof
12/15/2004	CN1554749A Structure of recombined T4 bacteriophage of expression infectious cysticercosis virus VP2 protein and its use
12/15/2004	CN1180088C Method for producing broad adaptability, high specific activity phytase and acidic phosphoesterase using silkworm bioreactor
12/15/2004	CN1179973C HBV core antigen particles with multiple immunogenic components attached via peptide ligands
12/14/2004	US6831086 In presence of proteins which retain biological activity; synergistic with benzalkonium chloride; easily removed by adsorption on active carbon or dialysis
12/14/2004	US6830920 Rapid generation of recombinant adenoviral vectors
12/14/2004	US6830917 Method of isolation and purification of trypsin from pronase protease and use thereof
12/14/2004	US6830892 Detecting preferential viral particles in sample; obtain cell, incubate with viral nuclotide sequences, detect transduced cells, monitor cells for preferential phenotypes, detect target particles in preferential cells
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	US6830748 Recombinant RSV virus expression systems and vaccines
12/14/2004	US6830699 Process and means to prevent microorganisms blooming in an aquatic system
12/09/2004	WO2004106505A1 A gutless adenovirus vector and the construction method thereof
12/09/2004	WO2004106504A1 The recombinant adeno-associated viruses carrying the human gamma interferon and the metrod for preparing them
12/09/2004	WO2004091505A3 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
12/09/2004	WO2004085660A3 Improved alphavirus replicons and helper constructs
12/09/2004	WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004	US20040248298 Methods for purification of bacterial cells and components
12/09/2004	US20040248288 Compositions and methods for efficient aav vector production
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor
12/09/2004	US20040248081 Composition comprising latency-associated nuclear antigen (LANA) for use in identifying modulators which prevent viral association with genomic nucleotide sequences; treating viral infections and cell proliferative disorders; viricides
12/09/2004	US20040247569 Reduction in bacterial colonization by administering bacteriophage compositions
12/08/2004	EP1484409A2 Expression vector comprising short-lived drug resistance gene
12/08/2004	EP1484391A1 Vaccine against mumps
12/08/2004	EP1483391A1 Engineered baculoviruses and their use
12/08/2004	EP1483385A2 Compositions and methods for generating an immune response
12/08/2004	EP1483377A1 Recovery of viruses
12/08/2004	EP1483376A1 High throughput system for producing recombinant viruses using site-specific recombination
12/08/2004	EP1483375A1 A method for producing recombinant viruses using site-specific recombination
12/08/2004	CN1553961A Membrane virus host range mutations and their uses as vaccine substrates
12/08/2004	CN1552880A Use and constructing plan of anticancer recombined gland virus with tumour CHK1 as target of medicine
12/08/2004	CN1552879A Use and obtain of inactivating lumour CHK1 gene anticancer recombined gland virus constituent
12/08/2004	CN1552878A Use and obtain of selective inactivating tumour PLK1 anticancer recombined gland virus constituent
12/08/2004	CN1552877A Use and constructing method for anticancer recombined gland virus with tumour cell PLK1 as target of medicine
12/08/2004	CN1552851A False virus of SARS coronavirus and its preparation and use
12/08/2004	CN1552850A Recombined human gama interferon gland virus and preparation of products therefrom
12/08/2004	CN1179040C Cyclic peptides
12/08/2004	CN1179039C Preparing method for preservative agent for chicken newcastle disease virus
12/08/2004	CN1178698C Attenuated pig genital and respiratory syndrome virus and its using method
12/08/2004	CN1178697C Infectious bursits vaccine
12/07/2004	US6828139 Production of replicative hepatitis C virus
12/07/2004	US6828138 Recombinant sendai virus vector including a gene encoding a chemokine
12/07/2004	US6827937 HBV capsid-binding peptide immunogens
12/02/2004	WO2004104190A2 Methods and compositions for the production of adenoviral vectors
12/02/2004	WO2004104189A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004	WO2004104033A2 Viruses dependent on inducing agents for viral entry into a host cell

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 267